Delivery Order SPE2DB20D9135-SPE2DB24FZW79
Award Date 3/20/24
Potential Completion Date 3/21/24
Potential Value $3.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,892.90 contract, with a completion date of April 16, 2024, is to provide the DLA's Medical Supply Chain division with 100 mg/mL Nucala auto-injectors. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, that allows the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $11,357.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of NUCALA 100 MG/ML auto-injectors and has a period of performance through March 22, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract with DLA, valued at up to $4,999,999, which enables the agency to issue delivery orders for a broad range...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $3,785.80 contract is for the supply of NUCALA 100 MG/ML AUTO-INJECTOR medical products. This order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of...
- The Defense Logistics Agency (DLA) awarded a $3,785.80 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NUCALA 100 MG/ML auto-injectors to support the medical needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which provides...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,785.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NUCALA 100 MG/ML AUTO-INJECTORML, a biologic medication, to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,357.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which runs through March 13, 2024, is for the supply of Nucala 100 mg/mL auto-injector medication. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order worth $106,002.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, placed under the DLA's SPE2DB Indefinite Delivery Contract (IDC), is for the delivery of NUCALA 100 MG/ML auto-injectors to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant IDC with the DLA, valued...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract worth $3,785.80 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of NUCALA 100 MG/ML auto-injectors. This order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through 2025. This larger contract enables DLA to place delivery orders for a broad range of...
- The U.S. Defense Logistics Agency (DLA) has awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,357.40, is for the delivery of NUCALA 100 MG/ML AUTO-INJECTORML. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, to provide a comprehensive range of pharmaceutical items...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,892.90 contract is for the delivery of Nucala 100 mg/mL auto-injectors. This delivery order falls under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to military healthcare facilities. The...
- SPE2DB20D9135Indefinite Delivery Contract
- SPE2DB20D9135-SPE2DB24FZW79Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,785.80 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which has a completion date of March 21, 2024, is for the supply of NUCALA 100 MG/ML auto-injectors to support the medical needs of military personnel and their dependents. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to military health facilities worldwide. This contract has no set-aside designation.
Generated 1/9/25, 9:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 3/20/24 |